Thomas Hatschek

Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing

Charissa Kim, Ruli Gao, Emi Sei et al. · Cell · 2018 · 1.2K citations

Life Sciences, Molecular Biology, Oncology +16

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.

P Dombernowsky, I E Smith, Geoffrey Falkson et al. · Journal of Clinical Oncology · 1998 · 640 citations

Medicine, Oncology, Pharmacology +16

Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

Linda S. Lindström, Eva Karlsson, Ulla Wilking et al. · Journal of Clinical Oncology · 2012 · 535 citations

Medicine, Oncology, Pathology +13

An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression

Asís Palazón, Petros A. Tyrakis, David Macías et al. · Cancer Cell · 2017 · 530 citations · Full text

Medicine, Cancer Biology, Oncology +17

Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial☆

Filippo Montemurro, Suzette Delaloge, Carlos H. Barrios et al. · Annals of Oncology · 2020 · 342 citations · Full text

Medicine, Oncology, Pharmacology +17